ITHUF · iANTHUS CAPITAL HOLDINGS, INC.
Substantial doubt about the company's ability to continue as a going concern.
“While we believe that we have funding necessary for us to continue as a going concern, we may need to raise additional capital and there can be no assurance that such capital will be available to us on favorable terms, if at all. As such, these material circumstances cast substantial doubt on our ability to continue as a going concern for a period of no less than 12 months from the date of this report, and our unaudited interim condensed consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $139.54M | $143.99M | $167.57M | $159.24M | $163.21M | $203.02M | $151.67M | |
| $76.85M | $78.29M | $92.45M | $96.07M | $88.78M | $93.49M | $69.83M | |
| $62.69M | $65.7M | $75.11M | $63.17M | $74.43M | $109.53M | $81.84M | |
| — | 45.63% | 44.83% | 39.67% | 45.6% | 53.95% | 53.96% | |
| $56.14M | $60.89M | $62.18M | $67.86M | $128.09M | $96.97M | $98.38M | |
| — | $10.2M | $13.9M | $13.9M | $16.4M | $15.4M | $15.5M | |
| $19.36M | $19.29M | $24.74M | $27.17M | $31.39M | $31.04M | $27.92M | |
| $75.29M | $81.11M | $83.63M | $92.9M | $186.89M | $133.31M | $331.73M | |
| — | — | — | — | $0 | $1.9M | $0 | |
| -$12.61M | -$15.42M | -$8.51M | -$29.74M | -$112.46M | -$23.78M | -$249.89M | |
| — | -10.71% | -5.08% | -18.67% | -68.9% | -11.71% | -164.76% | |
| $6.76M | $3.87M | $16.22M | -$2.57M | -$81.07M | $7.26M | -$221.97M | |
| $16.72M | $16.6M | $17.17M | $15.75M | $18.66M | $1.7M | $3.4M | |
| — | — | — | — | $86K | $517K | $403K | |
| $101K | -$13K | -$211K | -$183K | $0 | $0 | $182K | |
| -$32.44M | -$23.17M | -$25.31M | -$49.46M | -$438.7M | -$55.75M | -$294.73M | |
| $22.93M | $17.04M | -$17.68M | $27.16M | $10.69M | $21.74M | $18.63M | |
| -$55.37M | -$40.2M | -$7.64M | -$76.62M | -$449.39M | -$77.49M | -$313.36M | |
| — | -27.92% | -4.56% | -48.12% | -275.34% | -38.17% | -206.61% | |
| USD/shares | -$0.01 | -$0.01 | $0.00 | -$0.01 | -$0.13 | -$0.45 | — |
| USD/shares | -$0.01 | -$0.01 | $0.00 | -$0.01 | -$0.13 | -$0.45 | — |
| shares | — | 6.7B | 6.54B | 6.44B | 3.37M | 171.72K | 171.65M |
| shares | — | 6.7B | 6.54B | 6.44B | 3.37M | 171.72K | 171.65M |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 38 similar-size Drug Manufacturers - Specialty & Generic companies (of 95 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Eastern Region | $133,605,000 | $128,553,000 | $105,922,000 | $96,478,000 | $128,979,000 | $91,149,000 |
| Western Region | $10,381,000 | $39,014,000 | $53,088,000 | $65,644,000 | $72,424,000 | $57,613,000 |
| Other | — | — | $227,000 | $1,091,000 | $1,615,000 | $2,907,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Ianthus Branded Products | $63,168,000 | $84,904,000 | $87,545,000 | $86,626,000 | $117,617,000 | $83,688,000 |
| Third Party Branded Products | $55,128,000 | $64,506,000 | $61,108,000 | $66,959,000 | $64,267,000 | $48,024,000 |
| Wholesale Bulk Other Products | $25,690,000 | $18,157,000 | $10,584,000 | $9,628,000 | $21,134,000 | $19,957,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Eastern Region | $4,684,000 | $12,463,000 | -$6,971,000 |
| Western Region | -$963,000 | -$927,000 | $1,103,000 |
| Other | -$19,139,000 | -$20,049,000 | -$23,867,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Eastern Region | 3.5% | 9.7% | -6.6% |
| Western Region | -9.3% | -2.4% | 2.1% |
| Other | — | — | -10514.1% |